Literature DB >> 17612665

Three-dimensional echocardiography and left bundle branch block: prime time in cardiology.

M M J Cramer1, B W De Boeck.   

Abstract

Entities:  

Year:  2007        PMID： 17612665      PMCID： PMC1847758          DOI： 10.1007/bf03085960

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  13 in total

Review 1.  Role of real time 3D echocardiography in evaluating the left ventricle.

Authors:  Mark J Monaghan
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

Review 2.  The expanding prognostic role of late gadolinium enhanced cardiac magnetic resonance.

Authors:  Christopher M Kramer
Journal:  J Am Coll Cardiol       Date:  2006-10-31       Impact factor: 24.094

3.  Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion.

Authors:  Kevin Vernooy; Xander A A M Verbeek; Maaike Peschar; Harry J G M Crijns; Theo Arts; Richard N M Cornelussen; Frits W Prinzen
Journal:  Eur Heart J       Date:  2004-11-29       Impact factor: 29.983

4.  Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization.

Authors:  Alison M Duncan; Eric Lim; Jonathan Clague; Derek G Gibson; Michael Y Henein
Journal:  Eur Heart J       Date:  2006-08-01       Impact factor: 29.983

Review 5.  The left bundle branch block revised with novel imaging modalities.

Authors:  J van Dijk; H F J Mannaerts; T Germans; H A Hauer; P Knaapen; C A Visser; O Kamp
Journal:  Neth Heart J       Date:  2006-11       Impact factor: 2.380

6.  Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.

Authors:  Jeroen J Bax; Gabe B Bleeker; Thomas H Marwick; Sander G Molhoek; Eric Boersma; Paul Steendijk; Ernst E van der Wall; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

Review 8.  Mechano-electric feedback and arrhythmias.

Authors:  Ursula Ravens
Journal:  Prog Biophys Mol Biol       Date:  2003 May-Jul       Impact factor: 3.667

9.  Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism.

Authors:  Heikki Ukkonen; Rob S B Beanlands; Ian G Burwash; Robert A de Kemp; Claude Nahmias; Ernest Fallen; Michael R S Hill; Anthony S L Tang
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

10.  Influence of left bundle branch block on left ventricular volumes, ejection fraction and regional wall motion.

Authors:  J A Brunekreeft; M Graauw; P A R de Milliano; J T Keijer
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380
View more
  5 in total

1.  Gated SPECT in left bundle branch block: from improved diagnosis to improved treatment.

Authors:  E E van der Wall; J J Bax; J W Jukema; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-15       Impact factor: 2.357

2.  Mitral valve prolapse: a source of arrhythmias?

Authors:  E E van der Wall; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

3.  Distal protection beneficial?

Authors:  E E van der Wall; J J Bax; J W Jukema; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

4.  Speckle tracking: distinction of physiologic from pathologic LVH?

Authors:  E E van der Wall; V Delgado; E R Holman; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-24       Impact factor: 2.357

5.  CMR-determined scar volume: predictive for ventricular tachycardias?

Authors:  E E van der Wall; K Zeppenfeld; J J Bax; H M Siebelink; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2011-10       Impact factor: 2.357
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.